5-Aminobenzimidazole → HCID 178424603, compound
Reaction equation
Cl[C:2](OC1C=CC([N+]([O-])=O)=CC=1)=[O:3].[NH2:14][C:15]1[CH:23]=[CH:22][C:18]2[N:19]=[CH:20][NH:21][C:17]=2[CH:16]=1.[NH2:24][CH2:25][C:26]([C:28]1[CH:33]=[CH:32][C:31](Cl)=[C:30]([CH3:35])[CH:29]=1)=O>C(Cl)Cl>[NH:19]1[C:18]2[CH:22]=[CH:23][C:15]([N:14]3[CH:26]([C:28]4[CH:29]=[C:30]([CH3:35])[CH:31]=[CH:32][CH:33]=4)[CH2:25][NH:24][C:2]3=[O:3])=[CH:16][C:17]=2[N:21]=[CH:20]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
The compound was synthesized as hydrochloride salt by the following procedure. 4-Nitrophenyl chloroformate (0.564 g, 3.5 mmol) was dissolved CH2Cl2, cooled down to 0° C. and 5-aminobenzimidazole (0.466 g, 3.5 mmol) was added slowly. The mixture was kept at 0° C. for 30 min and then the mixture was allowed to adapt ambient temperature. The mixture was stirred at ambient temperature for 2 h. The resulted solid was withdrawn by suction, dried and taken up in a small amount of DMF. To the solution aminomethyl-(4-chloro-3-methylphenyl)ketone (0.774, 3.5 mmol) and TEA (1.46 ml, 10.5 mmol) was added. The mixture was kept at 40° C. for 2 h. The solvent was removed and purified by means of preparative HPLC. The remains were re-dissolved in MeOH and a small amount of HCl was added (1-2%). The solution was subjected to hydrogenation (PdC, 10% on charcoal, 4 bar, 60° C.) for 4 h. The catalyst was removed by filtration through a pad of CELITE® and the solvent was removed and purified by means of preparative HPLC.
Workup
- customto adapt ambient temperature
- customThe resulted solid was withdrawn by suction
- customdried
- waitThe mixture was kept at 40° C. for 2 h
- customThe solvent was removed
- custompurified by means of preparative HPLC
- dissolutionThe remains were re-dissolved in MeOH
- additiona small amount of HCl was added (1-2%)
- waitThe solution was subjected to hydrogenation (PdC, 10% on charcoal, 4 bar, 60° C.) for 4 h
- customThe catalyst was removed by filtration through a pad of CELITE®
- customthe solvent was removed
- custompurified by means of preparative HPLC
Sources & evidence
- ORD record
- ord-0cf8839902024e5aa083606546018a15
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09173885B2
Reaction notes
Loading…